Sfoglia per AUTORE
CAVALOT F
Collezione AOU San Luigi di Orbassano

  

Items : 45

Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) Societies. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2021 Jun 7;31(6):1671-1690. doi: 10.1016/j.numecd.2021.02.029. Epub 2021
2021
AOU San Luigi di Orbassano

Avogaro A; Barillà F; Cavalot F; Consoli A; Federici M; Mancone M; Paolillo S; Pedrinelli R; Perseghin G; Perrone Filardi P; Scicali R; Sinagra G; Spaccarotella C; Indolfi C; Purrello F;

Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study. in Diabetes therapy : research, treatment and education of diabetes and related disorders / Diabetes Ther. 2020 Sep;11(9):2105-2119. doi: 10.1007/s13300-020-00871-5. Epub 2020 Jul 30.
2020
ASL Torino 5
AOU San Luigi di Orbassano

Guerzoni C; Cercone S; Bossi AC; De Cosmo S; Orsi E; Giorda CB; Gilio B; Cavalot F;

2020
AOU San Luigi di Orbassano

Barale C; Cavalot F; Frascaroli C; Bonomo K; Morotti A; Guerrasio A; Russo I;

Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2020 Feb 10;30(2):282-291. doi: 10.1016/j.numecd.2019.09.012. Epub 2019 S
2020
AOU San Luigi di Orbassano

Russo I; Cavalot F; Guerrasio A; Morotti A; Frascaroli C; Barale C; Bonomo K;

Hypercholesterolemia impairs the Glucagon-like peptide 1 action on platelets: Effects of a lipid-lowering treatment with simvastatin. in Thrombosis research / Thromb Res. 2019 Aug;180:74-85. doi: 10.1016/j.thromres.2019.06.010. Epub 2019 Jun 15.
2019
AOU San Luigi di Orbassano

Barale C; Frascaroli C; Cavalot F; Russo I;

Outcomes of integrated management versus specialized care for patients with type 2 diabetes: An observational study. in Diabetes research and clinical practice / Diabetes Res Clin Pract. 2018 Jun;140:208-215. doi: 10.1016/j.diabres.2018.03.056. Epub 2018 Apr 5.
2018
AOU San Luigi di Orbassano

Sabione I; Cavalot F; Paccotti P; Massucco P; Vigna-Taglianti FD;

Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study. in Diabetes therapy : research, treatment and education of diabetes and related disorders / Diabetes Ther. 2018 Aug;9(4):1477-1490. doi: 10.1007/s13300-018-0452-y. Epub 2018 Jun 1.
2018
AOU San Luigi di Orbassano

Fadini GP; Bottigliengo D; D'Angelo F; Cavalot F; Bossi AC; Zatti G; Baldi I; Avogaro A;

Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia. in BioMed research international / Biomed Res Int. 2018 Oct 1;2018:6508709. doi: 10.1155/2018/6508709. eCollection 2018.
2018
AOU San Luigi di Orbassano

Barale C; Frascaroli C; Senkeev R; Cavalot F; Russo I;

Cardioprotective Properties of Human Platelets Are Lost in Uncontrolled Diabetes Mellitus: A Study in Isolated Rat Hearts. in Frontiers in physiology / Front Physiol. 2018 Jul 10;9:875. doi: 10.3389/fphys.2018.00875. eCollection 2018.
2018
AOU San Luigi di Orbassano

Russo I; Femminò S; Barale C; Tullio F; Geuna S; Cavalot F; Pagliaro P; Penna C;

Platelets, diabetes and myocardial ischemia/reperfusion injury. in Cardiovascular diabetology / Cardiovasc Diabetol. 2017 May 31;16(1):71. doi: 10.1186/s12933-017-0550-6.
2017
AOU San Luigi di Orbassano

Russo I; Penna C; Musso T; Popara J; Alloatti G; Cavalot F; Pagliaro P;

Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation. in Thrombosis and haemostasis / Thromb Haemost. 2017 Jun 2;117(6):1115-1128. doi: 10.1160/TH16-07-0586. Epub 2017 Apr 13.
2017
AOU San Luigi di Orbassano

Barale C; Buracco S; Cavalot F; Frascaroli C; Guerrasio A; Russo I;

Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies. in Medicinal research reviews / Med Res Rev. 2015 Sep;35(5):968-1031. doi: 10.1002/med.21349. Epub 2015 May 6.
2015
AOU San Luigi di Orbassano

Sottero B; Gargiulo S; Russo I; Barale C; Poli G; Cavalot F;

Leptin and vascular smooth muscle cells. in Current pharmaceutical design / Curr Pharm Des. 2014;20(4):625-34. doi: 10.2174/13816128113199990022.
2014
AOU San Luigi di Orbassano

Trovati M; Doronzo G; Barale C; Vaccheris C; Russo I; Cavalot F;

Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress. in Atherosclerosis / Atherosclerosis. 2011 May;216(1):44-53. doi: 10.1016/j.atherosclerosis.2011.01.019. Epub 2011 Jan 21
2011
AOU San Luigi di Orbassano

Doronzo G; Viretto M; Russo I; Mattiello L; Di Martino L; Cavalot F; Anfossi G; Trovati M;

In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin. in Obesity (Silver Spring, Md.) / Obesity (Silver Spring). 2010 Apr;18(4):788-97. doi: 10.1038/oby.2009.302. Epub 2009 Oct 15.
2010
AOU San Luigi di Orbassano

Russo I; Traversa M; Bonomo K; De Salve A; Mattiello L; Del Mese P; Doronzo G; Cavalot F; Trovati M; Anfossi G;

Does pancreatic elastase-1 in stools predict steatorrhea in type 1 diabetes? in Diabetes care / Diabetes Care. 2006 Mar;29(3):719-21. doi: 10.2337/diacare.29.03.06.dc05-1389.
2006
AOU San Luigi di Orbassano

Cavalot F; Bonomo K; Fiora E; Bacillo E; Salacone P; Chirio M; Gaia E; Trovati M;

Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2006 Mar;91(3):813-9. doi: 10.1210/jc.2005-1005. Epub 2005 Dec 13.
2006
AOU San Luigi di Orbassano

Cavalot F; Petrelli A; Traversa M; Bonomo K; Fiora E; Conti M; Anfossi G; Costa G; Trovati M;

2004
AOU San Luigi di Orbassano

Cavalot F; Bonomo K; Perna P; Bacillo E; Salacone P; Gallo M; Mattiello L; Trovati M; Gaia E;

Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions. in European journal of clinical investigation / Eur J Clin Invest. 2002 Mar;32(3):179-86. doi: 10.1046/j.1365-2362.2002.00965.x.
2002
AOU San Luigi di Orbassano

Trovati M; Ponziani MC; Massucco P; Anfossi G; Mularoni EM; Burzacca S; Tassone F; Perna P; Traversa M; Cavalot F;

2002
AOU San Luigi di Orbassano

Russo I; Massucco P; Mattiello L; Cavalot F; Anfossi G; Trovati M;

Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. in Thrombosis research / Thromb Res. 2002 Jan 1;105(1):71-8. doi: 10.1016/s0049-3848(01)00412-1.
2002
AOU San Luigi di Orbassano

Anfossi G; Russo I; Massucco P; Mattiello L; Cavalot F; Balbo A; Trovati M;

White blood cell count is positively correlated with albumin excretion rate in subjects with type 2 diabetes. in Diabetes care / Diabetes Care. 2002 Dec;25(12):2354-5. doi: 10.2337/diacare.25.12.2354-a.
2002
AOU San Luigi di Orbassano

Cavalot F; Massucco P; Perna P; Traversa M; Anfossi G; Trovati M;

Afternoon hypoglycaemia in Type 2 diabetes: lessons from blood glucose profiles. in Diabetes, nutrition & metabolism / Diabetes Nutr Metab. 2002 Dec;15(6):439-43.
2002
AOU San Luigi di Orbassano

Trovati M; Traversa M; Cavalot F;

2001
AOU San Luigi di Orbassano

Anfossi G; Russo I; Massucco P; Mattiello L; Balbo A; Cavalot F; Trovati M;

N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. in European journal of clinical investigation / Eur J Clin Invest. 2001 May;31(5):452-61. doi: 10.1046/j.1365-2362.2001.00815.x.
2001
AOU San Luigi di Orbassano

Anfossi G; Russo I; Massucco P; Mattiello L; Cavalot F; Trovati M;

Modulation of human platelet function by L-canavanine: differential effects of low and high concentrations. in General pharmacology / Gen Pharmacol. 1999 Mar;32(3):321-8. doi: 10.1016/s0306-3623(98)00193-1.
1999
AOU San Luigi di Orbassano

Anfossi G; Massucco P; Mattiello L; Cavalot F; Perna P; Giori A; Tassone F; Trovati M;

1999
AOU San Luigi di Orbassano

Trovati M; Massucco P; Mattiello L; Costamagna C; Aldieri E; Cavalot F; Anfossi G; Bosia A; Ghigo D;

1998
AOU San Luigi di Orbassano

Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M;

1997
AOU San Luigi di Orbassano

Trovati M; Anfossi G; Massucco P; Mattiello L; Costamagna C; Piretto V; Mularoni E; Cavalot F; Bosia A; Ghigo D;

Interplay between milrinone and adenosine in the inhibition of human platelet response. in General pharmacology / Gen Pharmacol. 1996 Oct;27(7):1149-54. doi: 10.1016/s0306-3623(96)00050-x.
1996
AOU San Luigi di Orbassano

Anfossi G; Massucco P; Piretto V; Mularoni E; Cavalot F; Mattiello L; Trovati M;

Nonenzymatic glycation of fibronectin impairs adhesive and proliferative properties of human vascular smooth muscle cells. in Metabolism: clinical and experimental / Metabolism. 1996 Mar;45(3):285-92. doi: 10.1016/s0026-0495(96)90280-2.
1996
AOU San Luigi di Orbassano

Cavalot F; Anfossi G; Russo I; Mularoni E; Massucco P; Mattiello L; Burzacca S; Hahn AW; Trovati M;

1996
AOU San Luigi di Orbassano

Trovati M; Massucco P; Mattiello L; Piretto V; Cavalot F; Mularoni E; Anfossi G;

Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients. in Diabetes / Diabetes. 1995 Nov;44(11):1318-22. doi: 10.2337/diab.44.11.1318.
1995
AOU San Luigi di Orbassano

Trovati M; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Piretto V; Cavalot F; Anfossi G;

1995
AOU San Luigi di Orbassano

Trovati M; Massucco P; Mattiello L; Cavalot F; Mularoni E; Hahn A; Anfossi G;

Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets. in General pharmacology / Gen Pharmacol. 1994 Oct;25(6):1093-100. doi: 10.1016/0306-3623(94)90123-6.
1994
AOU San Luigi di Orbassano

Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M;

1994
AOU San Luigi di Orbassano

Trovati M; Massucco P; Mattiello L; Mularoni E; Cavalot F; Anfossi G;

Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost. in Prostaglandins, leukotrienes, and essential fatty acids / Prostaglandins Leukot Essent Fatty Acids. 1993 Nov;49(5):839-45. doi: 10.1016/0952-3278(93)90207-d.
1993
AOU San Luigi di Orbassano

Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M;

Effect of dopamine on adenosine 3',5'-cyclic monophosphate levels in human platelets. in General pharmacology / Gen Pharmacol. 1993 Mar;24(2):435-8. doi: 10.1016/0306-3623(93)90329-v.
1993
AOU San Luigi di Orbassano

Anfossi G; Massucco P; Mularoni E; Mattiello L; Cavalot F; Burzacca S; Trovati M;

Insulin stimulates the polymorphonuclear leukocyte chemokinesis. in Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme / Horm Metab Res. 1993 Jun;25(6):321-2. doi: 10.1055/s-2007-1002109.
1993
AOU San Luigi di Orbassano

Cavalot F; Anfossi G; Russo I; Mularoni E; Massucco P; Burzacca S; Mattiello L; Trovati M;

Studies on the effect of dopamine on the human platelet response. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 1992 Sep;19(9):613-8. doi: 10.1111/j.1440-1681.1992.tb00513.x.
1992
AOU San Luigi di Orbassano

Anfossi G; Massucco P; Mularoni E; Cavalot F; Burzacca S; Mattiello L; Trovati M;

A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents. in Diabetic medicine : a journal of the British Diabetic Association / Diabet Med. 1992 Mar;9(2):134-7. doi: 10.1111/j.1464-5491.1992.tb01749.x.
1992
AOU San Luigi di Orbassano

Trovati M; Burzacca S; Mularoni E; Massucco P; Cavalot F; Mattiello L; Anfossi G;

Calcium-channel blocking agents verapamil and diltiazem are inhibitors of vasopressin-induced human platelet activation. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 1991 Nov;18(11):767-73. doi: 10.1111/j.1440-1681.1991.tb01395.x.
1991
AOU San Luigi di Orbassano

Anfossi G; Mularoni E; Massucco P; Cavalot F; Burzacca S; Mattiello L; Trovati M;

Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood. in Prostaglandins, leukotrienes, and essential fatty acids / Prostaglandins Leukot Essent Fatty Acids. 1991 Nov;44(3):149-54. doi: 10.1016/0952-3278(91)90049-b.
1991
AOU San Luigi di Orbassano

Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G;

1991
AOU San Luigi di Orbassano

Anfossi G; Mularoni E; Trovati M; Massucco P; Cavalot F; Mattiello L; Emanuelli G;

Studies on inhibition of human platelet response by diltiazem. in General pharmacology / Gen Pharmacol. 1990;21(6):949-54. doi: 10.1016/0306-3623(90)90461-t.
1990
AOU San Luigi di Orbassano

Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte